CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Randomized Phase II Study of SOM230 and Everolimus in Castrate-Resistant, Chemotherapy-Naïve Prostate Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01313559
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:51.964300+00:00
Published At: 2018-01-16T00:00:00+00:00
Record Updated At: 2025-04-30
Results Posted At: 2018-01-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Castrate Resistant Prostate Cancer", "Chemotherapy Naive Prostate Cancer", "Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-04-30"
protocolSection.identificationModule.nctId: "NCT01313559"
protocolSection.identificationModule.officialTitle: "An Open Label Randomized Phase II Study of SOM230 and Everolimus in Castrate-Resistant, Chemotherapy-Na\u00efve Prostate Cancer Patients"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-01-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.